https://www.certara.com/publication/from-biological-mechanisms-to-causal-inference-quantitative-systems-pharmacology-and-causal-frameworks-in-drug-development/
QSP Meets Causal Inference in Drug Development | Certara
Sep 30, 2026 - New CPT tutorial co-authored by Certara's Piet van der Graaf shows how combining QSP and causal inference strengthens drug development decisions
causal inferencedrug developmentqspmeetscertara
https://www.quinten-health.com/quinten-health-partners-with-certara-to-advance-precision-medicine-and-health-economics/
Quinten Health Partners with Certara to Advance Precision Medicine and Health Economics - Data...
Nov 16, 2025 - Quinten Health partners with Certara to deliver an end-to-end suite of AI, pharmacometrics, and health economics solutions, enabling biopharma companies to...
precision medicinequintenhealthpartnerscertara
https://nevadatechjournal.com/article/897190497-certara-simcyp-simulator-results-replace-ten-human-trials-for-chronic-myeloid-leukemia-cml-therapy-asciminib
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML)...
chronic myeloid leukemiahuman trialscertarasimulatorresults
https://www.bio-trend.com.tw/certara%E6%96%B0%E8%97%A5%E8%87%A8%E5%BA%8A%E6%95%B8%E4%BD%8D%E5%8C%96%E7%B3%BB%E5%88%97%E7%A0%94%E8%A8%8E%E6%9C%83
Certara 新藥臨床數位化系列研討會 | 百昌生物醫藥科技
certara
https://www.certara.com.cn/white-paper/model-informed-strategies-for-adc-development/
Model-Informed Strategies for ADC Development | Certara
Sep 22, 2026 - Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen regulatory strategy, and support lifecycle...
modelinformedstrategiesadcdevelopment
https://www.certara.com/live-events/qsp-workshop-2026-in-japan-korea-mastering-scalable-ai-enabled-qsp-modeling-software-certara-iq/
QSP Workshop 2026 Japan & Korea – Hands-On Training with Certara IQ
Feb 19, 2026 - Join the 2026 QSP workshop in Japan or Korea to master AI-enabled QSP modeling with Certara IQ. Learn scalable model building, optimization, and real...
hands on trainingqspworkshopjapankorea
https://www.certara.com.cn/teams/christian-maass/
Christian Maass | Certara
christianmaasscertara
https://www.certara.com.cn/case-study/optimizing-dosing-and-regulatory-outcomes-in-duchenne-muscular-dystrophy-dmd-drug-development/
Duchenne Muscular Dystrophy (DMD) Drug Development | Certara
Oct 31, 2025 - 案例研究：Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy. 了解更多...
duchenne muscular dystrophydrug developmentdmdcertara
https://www.certara.com/blog/demystifying-cdisc-sdtm-and-adam/
Demystifying CDISC, SDTM, and ADaM | Certara
Aug 4, 2026 - Breaking down the basics of CDISC’s CDASH, SDTM and ADaM standards, to help you understand how they work and how to use them.
demystifyingcdiscsdtmadamcertara
https://www.druginteractionsolutions.org/blog/a-new-tag-on-data-type-pbpk-study-has-been-added-on-the-citation-level/
A New Tag has been Added to Identify PBPK Studies at the Citation/NDA Level - Certara Drug...
a newhas beenadded toat thetag
https://malavidafilms.com/forum/viewtopic.php?t=30199&sid=94c43c5a12245d21e5c5f3352d27a8e5
Malavida Films ~ Voir le sujet - Certara Phoenix 2026 v8.8.0
filmsvoirsujetcertaraphoenix
https://www.certara.com.cn/solutions/strategic-leadership/
Certara 战略领导力 | Certara
Jul 23, 2026 - Certara 战略领导力通过整合分散的开发活动、标准化各阶段数据与洞见，助力加速疗法上市。
certara
https://cran.stat.auckland.ac.nz/web/packages/Certara.NLME8/index.html
CRAN: Package Certara.NLME8
Interface to Certara's Nonlinear Mixed-Effects (NLME) modeling engine ('NLME-Engine') for pharmacokinetic and pharmacodynamic (PK/PD) modeling and simulation....
cranpackagecertara
https://www.certara.com.cn/poster/antidepressants-anxiolytics-and-statins-prediction-of-exposure-changes-due-to-aging/
Antidepressants, anxiolytics and statins: prediction of exposure changes due to aging. | Certara
due toantidepressantsanxiolyticsstatinsprediction
https://www.bruneipoliticalreview.com/article/920640015-certara-inc-shareholders-are-encouraged-to-reach-out-to-johnson-fistel-for-more-information-about-potentially-recovering-their-losses
Certara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About...
for more informationreach outcertaraincshareholders
https://markets.financialcontent.com/fatpitch.financials/article/gnwcq-2024-10-9-certara-to-report-third-quarter-2024-financial-results-on-november-6th-2024
Fat Pitch Financials - Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
third quarterfinancial resultsfatpitchfinancials
https://www.certara.com.cn/tag/evidence-and-access/page/4/
Evidence and Access Archives | 第 4 页，共 4 页 | Certara
evidenceaccessarchivescertara
https://grafa.com/en/company/certara/us/cert
Certara (NASDAQ: CERT) — Company Profile, Share Price & News | Grafa
Certara accelerates drug discovery with biosimulation software and services for the biopharmaceutical industry.
company profileshare pricecertaranasdaqnews
https://www.certara.com.cn/fact-sheet/basecase-turn-evidence-into-decisions-at-scale/
BaseCase® Turn Evidence into Decisions - at Scale | Certara
at scaleturnevidencedecisionscertara
https://statbase.ru/companies/certara/
Certara, Inc. (CERT) | Отчетность и показатели за всю историю
Финансовая отчетность Certara (США) за весь доступный период: выручка, прибыль, активы, долг и денежный поток. Фундаментальные показатели, финансовые...
certarainc
https://www.arsenalcapital.com/news/certara-launches-non-animal-navigator-solution
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal...
certaralaunchesnonanimalsolution
https://www.certara.com.cn/teams/fred-mahakian/
Fred Mahakian | Certara
fredcertara
https://www.certara.com/tag/conference-preclinical-lp/
Conference - Preclinical LP Archives | Certara
conferencepreclinicalarchivescertara
https://www.certara.com/accelerating-oncology-drugdevelopment-with-biosimulation-andregulatory-strategy/?_page=12
Accelerating Oncology Drug Development with Biosimulation and Regulatory Strategy | Certara
May 21, 2026 - With more than 80% of novel compounds to treat cancer coming from emerging biopharma, small biotechs are clearly betting big on oncology. But to achieve...
drug developmentacceleratingoncologybiosimulationregulatory
https://certainty.certara.com/team/pegy-foteinou-phd-bristol-myers-squibb/
Pegy Foteinou, PhD, Bristol-Myers Squibb | Certainty Brought to you by Certara
Nov 18, 2025 - personal info Dr. Pegy Foteinou is a Senior Director at Bristol-Myers Squibb leading the early-stage mechanistic pharmacology modeling group within the...
bristol myers squibbpegyphdcertaintybrought
https://www.appliedclinicaltrialsonline.com/view/certara-launches-codex-inform-drug-development-decisions-0
Certara Launches CODEx to Inform Drug Development Decisions | Applied Clinical Trials Online
Oct 15, 2026 - Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
drug developmentclinical trialscertaralaunchescodex
https://www.ki-syndikat.de/tools/certara-coauthor/
Certara CoAuthor im Überblick: Funktionen, Preise & Alternativen | KI-Syndikat
Generative-KI-Plattform für medizinisches und regulatorisches Schreiben, eingebettet in Microsoft Word.
certaracoauthorfunktionenpreisealternativen
https://www.financialcontent.com/quote/NQ:CERT
Certara, Inc. - Common Stock (CERT) Stock Price, News, Quote & History | FinancialContent
The current price of Certara, Inc. - Common Stock (CERT) is 9.2400 — it has gone up by +0.1100 (1.20%) today. Certara Inc is a leading provider of software and...
common stockcertaraincpricenews